Literature DB >> 17634823

Polycythaemia vera and JAK2 mutation.

P M Mannucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17634823     DOI： 10.1007/s11739-007-0044-8

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  2 in total

1.  Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis.

Authors:  Massimo Primignani; Giovanni Barosi; Gaetano Bergamaschi; Umberto Gianelli; Federica Fabris; Raffaella Reati; Alessandra Dell'Era; Paolo Bucciarelli; Pier Mannuccio Mannucci
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

Review 2.  The treatment of polycythaemia vera: an update in the JAK2 era.

Authors:  G Finazzi; T Barbui
Journal:  Intern Emerg Med       Date:  2007-03-31       Impact factor: 3.397
  2 in total
  1 in total

1.  Treatment outcome in a cohort of young patients with polycythemia vera.

Authors:  Marco Ruggeri; Silvia Finotto; Stefania Fortuna; Francesco Rodeghiero
Journal:  Intern Emerg Med       Date:  2010-07-06       Impact factor: 3.397
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.